MoxiRace Gold Equine Oral Gel  is indicated for the treatment of mixed cestodes and nematodes or arthropods infections in horses, caused by moxidectin and praziquantel sensitive strains of:

• Large strongyles:

. Strongylus vulgaris (adult stages)
. Strongylus edentatus (adult stages)
. Triodontophorus brevicauda (adults)
. Triodontophorus serratus (adults)
. Triodontophorus tenuicollis  (adults)

• Small strongyles (adults and intraluminal larval stages):

. Cyathostomum spp
. Cylicocyclus spp
. Cylicostephanus spp
. Cylicodontophorus spp
. Gyalocephalus spp

• Ascarids:

. Parascaris equorum(adults)
 

• Other species:

. Oxyuris equi (adult stages)
. Habronema muscae (adults)
. Gasterophilus intestinalis (L2, L3)
. Gasterophilus nasalis (L2, L3)
. Strongyloides westeri (adults)
. Trichostrongylus axei (adult stages)
 

• Tapeworm (adults):

. Anoplocephala perfoliata
. Anoplocephala magna
. Paranoplocephala mammillana

The egg reappearance period of small strongyles is 90 days.
The product is effective against (developing) intramucosal L4 stages of small strongyles.  At 8 weeks after treatment, early (hypobiotic) EL3 stages of small strongyles are eliminated.

• A single oral dose of 400 µg moxidectin/kg bodyweight and 2.5 mg praziquantel/kg bodyweight using the calibrated syringe of one gradation per 25 kg body weight.
• Do not underdose
• For oral use only.
• A single syringe treats a 700 kg horse.
• In the case of cestode treatment the dose of praziquantel in the product has been selected to the top end of the dosing range.

• Store below 25°C.  Discard after 6 months from the date of the first use.
• 14 g Syringe packed in a Primary Carton along with the Pack Insert.

Each gram contains:
Moxidectin BP (Vet) ……8 mg
Praziquantel…………….. 50 mg
Oxfendazole…………….. 200 mg
Excipients………………..q.s.